Author

Florentina Porsch

Medical University of ViennaORCID 0000-0002-2633-6632Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Research Focus:protein design· 1 Assay:protein structure· 1

Frequent Co-Authors

Alain TedguiiD· 1 shared Céline AlbalaaiD· 1 shared Christoph J. BinderiD· 1 shared David KlatzmanniD· 1 shared Fatima Saddouk· 1 shared Inès LeleuiD· 1 shared Joan TeyraiD· 1 shared Lauri PeiliD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Alain TedguiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targeting IL-2 to inflamed tissues via oxidation-specific epitopes enables third-generation bispecific IL-2 therapeutics

Thomas Vazquez, Monica Cuevas-martinez, Nicolas Billiald, Florentina Porsch, Marie Sion, Fatima Saddouk, Céline Albalaa, Lorena Zentilin, Lauri Peil, Joan Teyra, Tahar Bouceba, Inès Leleu, Sylviane Pied, Mart Ustav, Alain Tedgui, , David Klatzmann

This paper develops a third-generation IL-2 therapeutic that targets inflamed tissues via oxidation-specific epitopes, showing improved therapeutic benefit in multiple inflammation models.

bioRxiv · Sep 15, 2026 · PreprintImmunology